Vitaspring Biomedical VSBC
OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Total Debt (2017 - 2026)

Updated

Vitaspring Biomedical (VSBC) recorded Total Debt of $2.41 million in fiscal Q2 2027 (quarter ended Jul 31, 2026).

Analysis

Vitaspring Biomedical (VSBC) Total Debt (2017 - 2026) Analysis & Trends

At the end of FY2019 (ended Jan 31, 2019), Vitaspring Biomedical reported Total Debt of $18,350, up 126.5% from FY2018.

  • Across earlier fiscal years, Total Debt came in at $8,100 in FY2018 (+406.3%) and $1,600 in FY2017.
  • The fiscal Q2 2027 figure is the highest quarterly Total Debt in data going back to fiscal Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Vitaspring Biomedical 2.07 Mn 2.04 Mn - 2.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 2.41 Mn
Jul 31, 2020 15,200.00
Apr 30, 2020 8,660.00
Apr 30, 2019 18,350.00
Jan 31, 2019 18,350.00
Oct 31, 2018 18,200.00
Jan 31, 2018 8,100.00
Oct 31, 2017 8,100.00
Jan 31, 2017 1,600.00
API Access

Vitaspring Biomedical Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=VSBC&period=max&api_key=YOUR_API_KEY